HOHarald C. Ott

Harald C. Ott

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Harald C. Ott has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Invited Commentary: “Robotic Airway Resection Under Spontaneous Ventilation”

    by Harald C. Ott

    An abstract is unavailable. This article is available as a PDF only.


  • Can We Re-Engineer the Endocrine Pancreas?

    by Antonio Citro, Harald C. Ott

    Purpose of Review Engineering endocrine pancreatic tissue is an emerging topic in type 1 diabetes with the intent to overcome the current limitation of β cell transplantation. During islet isolation, the vascularized structure and surrounding extracellular matrix (ECM) are completely disrupted. Once implanted, islets slowly engraft and mostly are lost for the initial avascular phase. This review discusses the main building blocks required to engineer the endocrine pancreas: (i) islet niche ECM, (ii) islet niche vascular network, and (iii) new available sources of endocrine cells. Recent Findings Current approaches include the following: tissue engineering of endocrine grafts by seeding of native or synthetic ECM scaffolds with human islets, vascularization of native or synthetic ECM prior to implantation, vascular functionalization of ECM structures to enhance angiogenesis after implantation, generation of engineered animals as human organ donors, and embryonic and pluripotent stem cell-derived endocrine cells that may be encapsulated or genetically engineered to be immunotolerated. Summary Substantial technological improvements have been made to regenerate or engineer endocrine pancreatic tissue; however, significant hurdles remain, and more research is needed to develop a technology to integrate all components of viable endocrine tissue for clinical application.


  • Robotic Resection of Small Pulmonary Nodules after Image-Guided Marker Placement

    by Konstantinos P. Economopoulos, Leonidas Tapias, Brett Broussard, Philipp T. Moser, Amita Sharma, Joanne O. Shepard, Florian J. Fintelmann, Shaunagh McDermott, Douglas J. Mathisen, Harald C. Ott

  • Creation of a Bioengineered Skin Flap Scaffold with a Perfusable Vascular Pedicle

    by Bernhard J. Jank, Jeremy Goverman, Jacques P. Guyette, Jon M. Charest, Mark Randolph, Glenn R. Gaudette, Joshua R. Gershlak, Martin Purschke, Emilia Javorsky, Rosalynn M. Nazarian, et al.

    Full-thickness skin loss is a challenging problem due to limited reconstructive options, demanding 75 million surgical procedures annually in the United States. Autologous skin grafting is the gold standard treatment, but results in donor-site morbidity and poor aesthetics. Numerous skin substitutes are available on the market to date, however, none truly functions as full-thickness skin due to lack of a vascular network. The creation of an autologous full-thickness skin analogue with a vascular pedicle would result in a paradigm shift in the management of wounds and in reconstruction of full-thickness skin defects. To create a clinically relevant foundation, we generated an acellular skin flap scaffold (SFS) with a perfusable vascular pedicle of clinically relevant size by perfusion decellularization of porcine fasciocutaneous flaps. We then analyzed the yielded SFS for mechanical properties, biocompatibility, and regenerative potential in vitro and in vivo. Furthermore, we assessed the immunological response using an in vivo model. Finally, we recellularized the vascular compartment of an SFS and reconnected it to a recipient's blood supply to test for perfusability. Perfusion decellularization removed all cellular components with preservation of native extracellular matrix composition and architecture. Biaxial testing revealed preserved mechanical properties. Immunologic response and biocompatibility assessed via implantation and compared with native xenogenic skin and commercially available dermal substitutes revealed rapid neovascularization and complete tissue integration. Composition of infiltrating immune cells showed no evidence of allorejection and resembled the inflammatory phase of wound healing. Implantation into full-thickness skin defects demonstrated good tissue integration and skin regeneration without cicatrization. We have developed a protocol for the generation of an SFS of clinically relevant size, containing a vascular pedicle, which can be utilized for perfusion decellularization and, ultimately, anastomosis to the recipient vascular system after precellularization. The observed favorable immunological response and good tissue integration indicate the substantial regenerative potential of this platform.


  • Bioengineering Human Myocardium on Native Extracellular Matrix

    by Jacques P. Guyette, Jonathan M. Charest, Robert W. Mills, Bernhard J. Jank, Philipp T. Moser, Sarah E. Gilpin, Joshua R. Gershlak, Tatsuya Okamoto, Gabriel Gonzalez, David J. Milan, et al.

    Rationale:: More than 25 million individuals have heart failure worldwide, with ≈4000 patients currently awaiting heart transplantation in the United States. Donor organ shortage and allograft rejection remain major limitations with only ≈2500 hearts transplanted each year. As a theoretical alternative to allotransplantation, patient-derived bioartificial myocardium could provide functional support and ultimately impact the treatment of heart failure. Objective:: The objective of this study is to translate previous work to human scale and clinically relevant cells for the bioengineering of functional myocardial tissue based on the combination of human cardiac matrix and human induced pluripotent stem cell–derived cardiomyocytes. Methods and Results:: To provide a clinically relevant tissue scaffold, we translated perfusion-decellularization to human scale and obtained biocompatible human acellular cardiac scaffolds with preserved extracellular matrix composition, architecture, and perfusable coronary vasculature. We then repopulated this native human cardiac matrix with cardiomyocytes derived from nontransgenic human induced pluripotent stem cells and generated tissues of increasing 3-dimensional complexity. We maintained such cardiac tissue constructs in culture for 120 days to demonstrate definitive sarcomeric structure, cell and matrix deformation, contractile force, and electrical conduction. To show that functional myocardial tissue of human scale can be built on this platform, we then partially recellularized human whole-heart scaffolds with human induced pluripotent stem cell–derived cardiomyocytes. Under biomimetic culture, the seeded constructs developed force-generating human myocardial tissue and showed electrical conductivity, left ventricular pressure development, and metabolic function. Conclusions:: Native cardiac extracellular matrix scaffolds maintain matrix components and structure to support the seeding and engraftment of human induced pluripotent stem cell–derived cardiomyocytes and enable the bioengineering of functional human myocardial-like tissue of multiple complexities.


  • Engineered composite tissue as a bioartificial limb graft

    by Bernhard J. Jank, Linjie Xiong, Philipp T. Moser, Jacques P. Guyette, Xi Ren, Curtis L. Cetrulo, David A. Leonard, Leopoldo Fernandez, Shawn P. Fagan, Harald C. Ott


  • Enhanced Lung Epithelial Specification of Human Induced Pluripotent Stem Cells on Decellularized Lung Matrix

    by Sarah E. Gilpin, Xi Ren, Tatsuya Okamoto, Jacques P. Guyette, Hongmei Mou, Jayaraj Rajagopal, Douglas J. Mathisen, Joseph P. Vacanti, Harald C. Ott


  • Perfusion decellularization of human and porcine lungs: Bringing the matrix to clinical scale

    by Sarah Elizabeth Gilpin, Jacques P. Guyette, Gabriel Gonzalez, Xi Ren, John M. Asara, Douglas J. Mathisen, Joseph P. Vacanti, Harald C. Ott


  • Invited Commentary

    by Harald C. Ott